NCT04365101 Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 Status UNKNOWN Phase PHASE1/PHASE2
NCT04357340 The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 Status COMPLETED Phase NA
NCT04356443 Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection Status TERMINATED Phase N/A
NCT04355429 Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID) Status UNKNOWN Phase PHASE2
NCT04353245 Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System Status UNKNOWN Phase N/A
NCT04349618 Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia Status COMPLETED Phase NA
NCT04346693 An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 Status COMPLETED Phase PHASE3
NCT04345614 A Study of Auxora in Patients With Severe COVID-19 Pneumonia Status COMPLETED Phase PHASE2
NCT04334850 Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia Status COMPLETED Phase NA
NCT04331665 Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia Status TERMINATED Phase NA
NCT04320056 Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) Status UNKNOWN Phase NA
NCT04298606 A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence Status COMPLETED Phase EARLY_PHASE1